What is PharmEasy?
Headquartered in Mumbai, PharmEasy operates as a comprehensive online pharmacy and healthcare platform. By bridging the gap between patients and local pharmacies, the company has streamlined the procurement of essential medicines and diagnostic services. Its platform serves as a critical infrastructure component in India's healthcare delivery system, leveraging technology to enhance supply chain efficiency and patient convenience. As the digital health sector continues to mature, PharmEasy remains at the forefront, utilizing its extensive network to provide scalable, reliable, and accessible health solutions to a vast consumer base.
How much funding has PharmEasy raised?
PharmEasy has raised a total of $1.5B across 8 funding rounds:
Series A
$5M
Series B
$18M
Series C
$77.4M
Series D
$220M
Multiple Rounds
$1B
Other Financing Round
$216M
Series A (2015): $5M, investors not publicly disclosed
Series B (2017): $18M led by Aarin Capital, Orios Venture Partners, and Bessemer Venture Partners
Series C (2018): $77.4M supported by F-Prime Capital Partners, Bessemer Venture Partners, JM Financial, Fundamentum, Manipal Group, Nandan Nilekani, Eight Roads Ventures India, Think Investments, Trifecta Capital, and Orios Venture Partners
Series D (2019): $220M featuring Temasek
Series E (2021): $350M backed by CDPQ, Temasek, TPG, Think Investments, LGT Lightrock, Eight Roads Services, and Prosus Ventures
Unspecified (2021): $300M with participation from TPG, Temasek, and Kotak Group
Other Financing Round (2021): $350M led by Amansa Capital and ApaH Capital Management
Other Financing Round (2024): $216M, investors not publicly disclosed
Key Investors in PharmEasy
Temasek
Founded in 1974, Temasek is a global investment company headquartered in Singapore. We are a generational investor, seeking to make a difference always with tomorrow in mind.
CDPQ
Founded in 1965, Caisse de dépt et placement du Québec is a full service portfolio investment company managing institutional funds, primarily from public and private pension and insurance funds.
TPG
TPG is a global alternative asset management firm founded in 1992 with investment strategies spanning private equity, growth equity, impact investing, and real estate.
What's next for PharmEasy?
With the recent influx of $216M, PharmEasy is well-positioned to accelerate its strategic initiatives, focusing on deepening its market penetration and enhancing its technological infrastructure. The company is expected to prioritize the optimization of its logistics network and the expansion of its diagnostic service offerings. By leveraging its robust capital structure, PharmEasy aims to solidify its leadership in the e-pharmacy space while exploring new avenues for value creation in the broader health-tech ecosystem. The continued support from institutional backers suggests a long-term commitment to scaling operations and maintaining a competitive edge in the rapidly digitizing Indian healthcare market.
See full PharmEasy company page
